Edwards Lifesciences Corporation
General ticker "EW" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $44.0B (TTM average)
Edwards Lifesciences Corporation follows the US Stock Market performance with the rate: 56.4%.
Estimated limits based on current volatility of 1.2%: low 83.93$, high 85.91$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 15800 (-20.2%) as of 2024
- US accounted for 58.4% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Pandemic risks, Manufacturing/logistics/quality issues, Market competition, Vendor dependency, Cybersecurity threats
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [51.39$, 81.56$]
- 2025-12-31 to 2026-12-31 estimated range: [51.04$, 81.19$]
Financial Metrics affecting the EW estimates:
- Negative: with PPE of 28.5 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 25.34 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 76.58 > 63.39
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.66 > 6.04
- Negative: 0 < Inventory ratio change, % of 0.68
- Negative: 0.01 < Interest expense per share per price, % of 0.04
Short-term EW quotes
Long-term EW plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $4,464.00MM | $5,010.00MM | $5,439.80MM |
| Operating Expenses | $2,965.60MM | $3,701.10MM | $4,061.10MM |
| Operating Income | $1,498.40MM | $1,308.90MM | $1,378.70MM |
| Non-Operating Income | $21.10MM | $63.50MM | $169.40MM |
| Interest Expense | $19.20MM | $17.60MM | $19.80MM |
| R&D Expense | $843.60MM | $962.90MM | $1,053.00MM |
| Income(Loss) | $1,519.50MM | $1,372.40MM | $1,548.10MM |
| Taxes | $195.50MM | $152.40MM | $152.10MM |
| Other Income(Loss) | $197.90MM | $179.40MM | $2,773.70MM |
| Profit(Loss)* | $1,521.90MM | $1,402.40MM | $4,174.60MM |
| Stockholders Equity | $5,806.70MM | $6,650.00MM | $9,998.40MM |
| Inventory | $875.50MM | $903.50MM | $1,086.70MM |
| Assets | $8,292.50MM | $9,363.20MM | $13,055.30MM |
| Operating Cash Flow | $1,218.20MM | $895.80MM | $542.30MM |
| Capital expenditure | $264.80MM | $266.30MM | $252.40MM |
| Investing Cash Flow | $252.30MM | $173.80MM | $2,312.90MM |
| Financing Cash Flow | $-1,584.50MM | $-711.00MM | $-983.00MM |
| Earnings Per Share** | $2.46 | $2.31 | $6.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.